BJPsych Open (Mar 2021)

Comparing psychotropic medication prescribing in personality disorder between general mental health and psychological services: retrospective cohort study

  • Giouliana Kadra-Scalzo,
  • Jacqueline Garland,
  • Stephen Miller,
  • Chin-Kuo Chang,
  • Marcella Fok,
  • Richard D. Hayes,
  • Paul Moran,
  • Hitesh Shetty,
  • Allan H. Young,
  • Robert Stewart

DOI
https://doi.org/10.1192/bjo.2021.34
Journal volume & issue
Vol. 7

Abstract

Read online

Background Although no drugs are licensed for the treatment of personality disorder, pharmacological treatment in clinical practice remains common. Aims This study aimed to estimate the prevalence of psychotropic drug use and associations with psychological service use among people with personality disorder. Method Using data from a large, anonymised mental healthcare database, we identified all adult patients with a diagnosis of personality disorder and ascertained psychotropic medication use between 1 August 2015 and 1 February 2016. Multivariable logistic regression models were constructed, adjusting for sociodemographic, clinical and service use factors, to examine the association between psychological services use and psychotropic medication prescribing. Results Of 3366 identified patients, 2029 (60.3%) were prescribed some form of psychotropic medication. Patients using psychological services were significantly less likely to be prescribed psychotropic medication (adjusted odds ratio 0.48, 95% CI 0.39–0.59, P<0.001) such as antipsychotics, benzodiazepines and antidepressants. This effect was maintained following several sensitivity analyses. We found no difference in the risk for mood stabiliser (adjusted odds ratio 0.79, 95% CI 0.57–1.10, P = 0.169) and multi-class psychotropic use (adjusted odds ratio 0.80, 95% CI 0.60–1.07, P = 0.133) between patients who did and did not use psychological services. Conclusions Psychotropic medication prescribing is common in patients with personality disorder, but significantly less likely in those who have used psychological services. This does not appear to be explained by differences in demographic, clinical and service use characteristics. There is a need to develop clear prescribing guidelines and conduct research in clinical settings to examine medication effectiveness for this population.

Keywords